org placeholder image

Mark Baczkowski

Executive Director, Pharmacovigilance Operations at Mirati Therapeutics

  • LinkedIn
map
MIRATI THERAPEUTICS

MIRATI THERAPEUTICS

  • Employees count Employees 201-500
  • Revenue Revenue 50 Million to 100 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Mirati Therapeutics Org Chart and Mapping

Joseph Leveque

President and Chief Executive Officer

Employees

Brady Blackman

Oncology Account Manager at Mirati Therapeutics

Mason Israel

Regional Medical Affairs Director

Donghui Zhou

Senior Manager, Statistical Programming

Sahar Roshandel

Sr. Scientist, Chemical Process R&D

Lauren Schroeder

Senior Director of Market Access, Value & Patient Support Marketing

Michelle Richards

Vice President, Head of Marketing

Angel Aslo

Executive Director of Strategic Accounts

Denise Butler

Senior Director, Patient Services

Frequently Asked Questions Regarding Mark Baczkowski

Answer: Mark Baczkowski works for Mirati Therapeutics as Executive Director, Pharmacovigilance Operations

Answer: Mark Baczkowski’s role in Mirati Therapeutics is Executive Director, Pharmacovigilance Operations

Answer: Mark Baczkowski's email address is m***@gmail.com

Answer: Mark Baczkowski's business email address is m****@interceptpharma.com

Answer: Mark Baczkowski’s direct phone number is (***)-***-****

Answer: Mark Baczkowski works in the industry of: Biotechnology

Answer: Mark Baczkowski works Mirati Therapeutics located at 3545 Cray Ct, San Diego, California, 92121, United States

Answer: Mirati Therapeutics's Executive Director, Pharmacovigilance Operations is Mark Baczkowski

Answer: Mark Baczkowski contact details:

  • Phone number  :  (***)-***-****
  • Email  :  m****@interceptpharma.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access